EVMN
Evommune, Inc.
NYSE: EVMN · HEALTHCARE · BIOTECHNOLOGY
$23.80
-0.21% today
Updated 2026-04-30
Market cap
$914.15M
P/E ratio
—
P/S ratio
70.32x
EPS (TTM)
$-11.22
Dividend yield
—
52W range
$14 – $33
Volume
0.3M
Evommune, Inc. (EVMN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-624.00%
ROE
-54.40%
ROA
-33.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2023 | $5.00M | $-34.05M | 80.00% | -757.00% | -681.06% |
| 2024 | $7.00M | $-66.81M | 81.61% | -1,000.19% | -954.40% |
| 2025 | $13.00M | $-68.87M | 89.32% | -623.62% | -529.77% |